516 related articles for article (PubMed ID: 28385094)
1. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
[TBL] [Abstract][Full Text] [Related]
2. Breathing new life into West Nile virus therapeutics; discovery and study of zafirlukast as an NS2B-NS3 protease inhibitor.
Martinez AA; Espinosa BA; Adamek RN; Thomas BA; Chau J; Gonzalez E; Keppetipola N; Salzameda NT
Eur J Med Chem; 2018 Sep; 157():1202-1213. PubMed ID: 30193218
[TBL] [Abstract][Full Text] [Related]
3. Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.
Cregar-Hernandez L; Jiao GS; Johnson AT; Lehrer AT; Wong TA; Margosiak SA
Antivir Chem Chemother; 2011 May; 21(5):209-17. PubMed ID: 21566267
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 2-{6-[2-(5-phenyl-4H-{1,2,4]triazol-3-ylsulfanyl)acetylamino]benzothiazol-2-ylsulfanyl}acetamide scaffold.
Samanta S; Lim TL; Lam Y
ChemMedChem; 2013 Jun; 8(6):994-1001. PubMed ID: 23619931
[TBL] [Abstract][Full Text] [Related]
5. Phosphonate inhibitors of West Nile virus NS2B/NS3 protease.
Skoreński M; Milewska A; Pyrć K; Sieńczyk M; Oleksyszyn J
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):8-14. PubMed ID: 30362835
[TBL] [Abstract][Full Text] [Related]
6. SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease.
Colarusso S; Ferrigno F; Ponzi S; Pavone F; Conte I; Abate L; Beghetto E; Missineo A; Amaudrut J; Bresciani A; Paonessa G; Tomei L; Montalbetti C; Bianchi E; Toniatti C; Ontoria JM
Bioorg Med Chem; 2022 Mar; 57():116631. PubMed ID: 35123179
[TBL] [Abstract][Full Text] [Related]
7. Structure-Based Macrocyclization of Substrate Analogue NS2B-NS3 Protease Inhibitors of Zika, West Nile and Dengue viruses.
Braun NJ; Quek JP; Huber S; Kouretova J; Rogge D; Lang-Henkel H; Cheong EZK; Chew BLA; Heine A; Luo D; Steinmetzer T
ChemMedChem; 2020 Aug; 15(15):1439-1452. PubMed ID: 32501637
[TBL] [Abstract][Full Text] [Related]
8. West Nile Virus NS2B/NS3 protease as an antiviral target.
Chappell KJ; Stoermer MJ; Fairlie DP; Young PR
Curr Med Chem; 2008; 15(27):2771-84. PubMed ID: 18991636
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the West Nile virus protease substrate specificity and inhibitors.
Mueller NH; Yon C; Ganesh VK; Padmanabhan R
Int J Biochem Cell Biol; 2007; 39(3):606-14. PubMed ID: 17188926
[TBL] [Abstract][Full Text] [Related]
10. Miniature bovine pancreatic trypsin inhibitors (m-BPTIs) of the West Nile virus NS2B-NS3 protease.
Ang MJ; Lim HA; Poulsen A; Wee JL; Ng FM; Joy J; Hill J; Chia CS
J Enzyme Inhib Med Chem; 2016; 31(sup2):194-200. PubMed ID: 27241372
[TBL] [Abstract][Full Text] [Related]
11. Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases.
Nitsche C; Steuer C; Klein CD
Bioorg Med Chem; 2011 Dec; 19(24):7318-37. PubMed ID: 22094280
[TBL] [Abstract][Full Text] [Related]
12. Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity.
Stoermer MJ; Chappell KJ; Liebscher S; Jensen CM; Gan CH; Gupta PK; Xu WJ; Young PR; Fairlie DP
J Med Chem; 2008 Sep; 51(18):5714-21. PubMed ID: 18729351
[TBL] [Abstract][Full Text] [Related]
13. Profiling of flaviviral NS2B-NS3 protease specificity provides a structural basis for the development of selective chemical tools that differentiate Dengue from Zika and West Nile viruses.
Rut W; Groborz K; Zhang L; Modrzycka S; Poreba M; Hilgenfeld R; Drag M
Antiviral Res; 2020 Mar; 175():104731. PubMed ID: 32014497
[TBL] [Abstract][Full Text] [Related]
14. Cleavage targets and the D-arginine-based inhibitors of the West Nile virus NS3 processing proteinase.
Shiryaev SA; Ratnikov BI; Chekanov AV; Sikora S; Rozanov DV; Godzik A; Wang J; Smith JW; Huang Z; Lindberg I; Samuel MA; Diamond MS; Strongin AY
Biochem J; 2006 Jan; 393(Pt 2):503-11. PubMed ID: 16229682
[TBL] [Abstract][Full Text] [Related]
15. STD-NMR experiments identify a structural motif with novel second-site activity against West Nile virus NS2B-NS3 protease.
Schöne T; Grimm LL; Sakai N; Zhang L; Hilgenfeld R; Peters T
Antiviral Res; 2017 Oct; 146():174-183. PubMed ID: 28927677
[TBL] [Abstract][Full Text] [Related]
16. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
Wichapong K; Pianwanit S; Sippl W; Kokpol S
J Mol Recognit; 2010; 23(3):283-300. PubMed ID: 19693793
[TBL] [Abstract][Full Text] [Related]
17. Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease.
Schüller A; Yin Z; Brian Chia CS; Doan DN; Kim HK; Shang L; Loh TP; Hill J; Vasudevan SG
Antiviral Res; 2011 Oct; 92(1):96-101. PubMed ID: 21763725
[TBL] [Abstract][Full Text] [Related]
18. Pharmacophoric characteristics of dengue virus NS2B/NS3pro inhibitors: a systematic review of the most promising compounds.
Leonel CA; Lima WG; Dos Santos M; Ferraz AC; Taranto AG; de Magalhães JC; Dos Santos LL; Ferreira JMS
Arch Virol; 2018 Mar; 163(3):575-586. PubMed ID: 29147793
[TBL] [Abstract][Full Text] [Related]
19. Cell-active carbazole derivatives as inhibitors of the zika virus protease.
Rassias G; Zogali V; Swarbrick CMD; Ki Chan KW; Chan SA; Gwee CP; Wang S; Kaplanai E; Canko A; Kiousis D; Lescar J; Luo D; Matsoukas MT; Vasudevan SG
Eur J Med Chem; 2019 Oct; 180():536-545. PubMed ID: 31344613
[TBL] [Abstract][Full Text] [Related]
20. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]